• Nie Znaleziono Wyników

18-FDG PET/CT to reveal cardiac metastasis of pancreatic neuroendocrine cancer

N/A
N/A
Protected

Academic year: 2022

Share "18-FDG PET/CT to reveal cardiac metastasis of pancreatic neuroendocrine cancer"

Copied!
2
0
0

Pełen tekst

(1)

Address for correspondence: Dariusz Jagielak, MD, PhD, Department of Cardiosurgery, Medical University of Gdansk, ul. Dębinki 7, 80–291 Gdańsk, Poland, e-mail: darjag@gumed.edu.pl

Received: 11.10.2016 Accepted: 12.10.2016

18-FDG PET/CT to reveal cardiac metastasis of pancreatic neuroendocrine cancer

Dariusz Jagielak

1

, Milosz Jaguszewski

2

, Jan Rogowski

1

, Renata Zaucha

3

1Clinic of Cardiac and Vascular Surgery, Medical University of Gdansk, Poland

21st Department of Cardiology, Medical University of Gdansk, Poland

3Clinic of Oncology and Radiotherapy, Medical University of Gdansk, Poland

A 49-year-old man was admitted to hospital complaining of intractable abdominal pain accom- panied by bouts of diarrhea, flushing, and weight loss. Patient history indicated neuroendocrine

pancreatic tumor (pNET) infiltrating Vater’s pa- pilla, duodenum and peripancreatic lymph nodes sealed by radical Whipple’s operation. The inoper- able multifocal relapse in the abdomen and pelvis

Figure 1. A. Radiotracer accumulated in the cardiac apex (green arrow). Cardiac apex in computed tomography and echocardiography with no pathological structures (B, inset). Surgical excision of the tumor (C, D); LV — left ventricle;

RV — right ventricle; RDP — right posterior descendent; OM — obtuse marginal.

clinical cardiology

Cardiology Journal 2017, Vol. 24, No. 1, 94–95 DOI: 10.5603/CJ.2017.0011 Copyright © 2017 Via Medica ISSN 1897–5593

94 www.cardiologyjournal.org

IMAGE IN CARDIOVASCULAR MEDICINE

(2)

was treated with 6 cycles of systemic chemo- therapy, subsequent radical surgical excision of the residual masses and 9-month treatment with somatostatin analog. A scintigraphy performed 3 months prior to admission revealed a lesion lo- cated in close proximity to the superior mesenteric artery. The recurrent tumor was excised, but due to positive surgical margins, adjuvant radiotherapy was administered. Subsequent positron emission tomography (PET)/computed tomography (CT) performed at admission documented recurrent lesion close to mesenteric artery together with an intensive accumulation of the radiotracer in the cardiac apex (Fig. 1A) not apparent in CT (Fig. 1B) and echocardiography (Fig. 1B, inset). Due to highly improved performance status of the patient reporting only grade 1 diarrhea, cardiosurgical exci- sion of a 5 cm tumor was successfully performed (Fig. 1C, D) and sealed by a sandwich Dacron patch (Fig. 1E). Due to expected progression of other in-

operable abdominal metastatic lesions, the patient was offered everolimus given orally at daily doses of 10 mg, and proceeded with no evidence of intol- erance. The postoperative course was uneventful, and the patient was discharged on the 6th day post intervention.

Cardiac metastases from pNET belong to ex- tremely unusual presentations of cancer progres- sion. Cardiovascular symptoms are usually masked by other more prominent adverse events of ad- vanced cancer. Up to 20% of cases may develop car- cinoid heart disease with right-sided valve lesions or heart failure. So far, little is known about the clinical impact of cardiac metastasis on overall survival.

Herein was presented a unique case of a car- diac apex metastasis detectable only on 18-FDG PET/CT, which was treated successfully with radical surgical excision.

Conflict of interest: None declared

www.cardiologyjournal.org 95

Dariusz Jagielak et al., 18-FDG PET/CT to reveal cardiac metastasis of pancreatic neuroendocrine cancer

Cytaty

Powiązane dokumenty

Effect of peptide receptor radionuclide therapy (PRRT) with tandem isotopes — [ 90 Y]Y/[ 177 Lu]Lu-DOTATATE in patients with disseminated neuroendocrine tumours depending on [

Positron emission tomography ( 18 FDG-PET) in the detection of medullary thyroid carcinoma metastases..

The result of PET/CT was considered a true nega- tive (TN) if it showed negative findings, and the result was considered false positive (FP) if the PET/CT showed posi- tive findings

Objectives: The present study evaluates the prognostic value of metabolic parameters related to the primary tumor identi- fied in preoperative fluorodeoxyglucose (FDG) positron

Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment.. Arch Gynecol

True positive results were found in 18 patients, including bone metastases in 7 persons, contralateral lung engagement in 4 persons, ad- renal gland metastases in 3 persons,

The patient was referred for another 18F-FDG PET/CT examination which showed moderately increased metabolic activity around the aortic valve with SUV max 4.1, SUV r(liver)..

Cel: Ocena przydatności pozytonowej emisyjnej tomografii komputerowej (positron emission tomography/computed tomography – PET/CT) z wykorzystaniem 18-fluorodeoksyglu- kozy (FDG)